(Press-News.org) The first successful human transplant of a kidney converted from blood type A to universal type O used special enzymes developed at the University of British Columbia to help prevent a mismatch and rejection of the organ.
Published today in Nature Biomedical Engineering, the achievement marks a major step toward helping thousands of patients get kidney transplants sooner.
In a first-in-human experiment, the enzyme-converted kidney was transplanted into a brain-dead recipient with consent from the family, allowing researchers to observe the immune response without risking a life.
For two days, the kidney functioned without signs of hyperacute rejection, the rapid immune reaction that can destroy an incompatible organ within minutes. By the third day, some blood-type markers reappeared, triggering a mild reaction, but the damage was far less severe than in a typical mismatch, and researchers saw signs that the body was beginning to tolerate the organ.
“This is the first time we’ve seen this play out in a human model,” said Dr. Stephen Withers, UBC professor emeritus of chemistry who co-led the enzyme development. “It gives us invaluable insight into how to improve long-term outcomes.”
The breakthrough is the result of more than a decade of work. In the early 2010s, Dr. Withers and colleague Dr. Jayachandran Kizhakkedathu, a UBC professor in the department of pathology and laboratory medicine and the Centre for Blood Research, were focused on making universal donor blood by stripping away the sugars that define blood types.
Those same sugars, or antigens, coat organ blood vessels. If a recipient’s immune system detects the wrong antigen, it attacks. Type-O patients—more than half of kidney waitlists—can only receive type-O organs, yet type-O kidneys are often given to others because they’re universally compatible. As a result, type-O patients typically wait two to four years longer, and many die waiting.
Traditional methods for overcoming blood-type incompatibility in transplants require days of intensive treatment to strip antibodies and suppress a recipient’s immune system—and require organs from living donors. This new approach changes the organ rather than the patient, meaning transplants could be performed faster, with fewer complications, and for the first time could unlock the use of blood-type mismatched organs from deceased donors—when every hour can determine whether a patient lives or dies.
The key to this approach is the 2019 discovery by the UBC team of two highly efficient enzymes that remove the sugar that defines type-A blood, effectively converting it to type O. “These enzymes are highly active, highly selective, and work at very low concentrations,” said Dr. Kizhakkedathu. “That made the whole concept feasible.”
The next challenge was applying this to whole organs, achieved in 2022 when a Toronto team showed lungs could be converted. After successful tests on blood, then lungs and kidneys (with the University of Cambridge) outside the body, the question remained: Could an enzyme-converted organ survive inside a human immune system?
The answer came in late 2023 on an overseas trip for Dr. Kizhakkedathu. “Our collaborators showed me their data where, using our enzymes, they had converted a human kidney and transplanted it into a brain-dead recipient. It was working beautifully.” He stayed up late to call Dr. Withers first thing in the B.C. morning. “I was so thrilled. It was a dream moment.”
Blood-type antigens act like nametags on cells, and the UBC enzymes act as molecular scissors, snipping off the ‘nametag’ that marks type A and revealing type O beneath. “It’s like removing the red paint from a car and uncovering the neutral primer,” said Dr. Withers. “Once that’s done, the immune system no longer sees the organ as foreign.”
Regulatory approval for clinical trials is the next hurdle, and the partner UBC spin-off company Avivo Biomedical will lead development of these enzymes for transplant application and to enable the creation of universal donor blood on demand for transfusion medicine.
The potential is enormous. “This is what it looks like when years of basic science finally connect to patient care,” said Dr. Withers. “Seeing our discoveries edge closer to real-world impact is what keeps us pushing forward.”
END
UBC enzyme technology clears first human test toward universal donor organs for transplantation
2025-10-03
ELSE PRESS RELEASES FROM THIS DATE:
Birds’ vocal warnings provide new insight into the origins of language
2025-10-03
ITHACA, N.Y. – Birds separated by vast geographic distances and millions of years of evolution share a remarkably similar learned vocal warning to identify parasitic enemies near their nests, an international team of researchers has found.
The results represent the first known example of an animal vocalization that is learned from an innate response shared across multiple species.
The findings, which will publish October 3, 2025 at 5am EST in Nature Ecology and Evolution, provide a glimpse into the role natural ...
Breakthrough results from elephant herpesvirus trial find vaccine to be safe
2025-10-03
The world’s first vaccine trial against elephant endotheliotropic herpesvirus (EEHV) – a leading cause of death in young Asian elephants – is safe and triggers a strong virus-fighting immune response, according to an international team led by the University of Surrey, in collaboration with Chester Zoo and the Animal and Plant Health Agency.
Published in Nature Communications, the proof‑of‑concept study involved adult elephants at Chester Zoo. No side effects were seen, and the vaccine successfully activated a key part of the immune system that helps fight viruses.
The elephants received a two‑step vaccination: first, a viral vector ...
Final step in the biosynthesis of iridoids elucidated
2025-10-03
Iridoids are a widespread and evolutionarily ancient class of plant secondary metabolites belonging to the terpenes. They occur in thousands of plant species and play an important role in defense and other interactions between plants and their environment. Iridoids are also found in foods such as olives and blueberries, and are believed to have anti-inflammatory properties. They are also essential precursors for many medically important compounds, including the cancer drug vinblastine and the ipecacuanha alkaloids found in the medicinal plants, sage-leaved alangium and ipecac root (see press release Two plant species invent the same ...
New antibiotic targets IBD — and AI predicted how it would work before scientists could prove it
2025-10-03
Study highlights:
The new antibiotic, enterololin, attacks and kills only a specific group of disease-causing bugs, which includes the type of E. coli that drives Crohn’s disease.
As such, the antibiotic is a promising new treatment option for people affected by Crohn’s and other IBD-related conditions. These conditions affect thousands of people across Canada and no cure currently exists.
Most antibiotics wipe out everything, including good bacteria. Enterololin, however, works like a scalpel, reducing the opportunity for opportunistic and/or drug-resistant ...
Glioblastomas affect much more than just the brain
2025-10-03
October 3, 2025—BRONX, NY—Scientists at Montefiore Einstein Comprehensive Cancer Center (MECCC) and Albert Einstein College of Medicine have shown for the first time that glioblastoma—the deadliest form of brain cancer—affects not just the brain but also erodes the skull, alters the makeup of skull marrow, and interferes with the body’s immune response. Drugs intended to inhibit skull-bone loss made the cancer more aggressive, according to results published today in Nature Neuroscience.
“Our discovery that this notoriously hard-to-treat brain cancer interacts with the body’s immune ...
Researchers uncover why mental maps fade with age
2025-10-03
In the realm of memories, “where” holds special importance. Where did I leave my keys? Where did I eat dinner last night? Where did I first meet that friend? Recalling locations is necessary for daily life, yet spatial memory — which keeps track of “where” — is one of the first cognitive abilities to fade in old age. And deficits earlier in life can be a telltale sign of dementia.
Now, researchers at Stanford Medicine and their colleagues are uncovering what goes awry in older brains when spatial memory falters and whether these changes can be prevented.
In a new study comparing young, ...
New mechanism revealed: How leukemia cells trick the immune system
2025-10-03
A research team at Lund University in Sweden has discovered a mechanism that helps acute myeloid leukemia cells to evade the body’s immune system. By developing an antibody that blocks the mechanism, the researchers could restore the immune system’s ability to kill the cancer cells in laboratory trials and in mice. The discovery is published in Nature Cancer.
In brief:
Facts about the study: peer-reviewed // basic research // translational research // in vivo // in vitro //
The study shows how a newly discovered mechanism helps leukemia cells to evade the immune system.
By generating ...
Genetic map reveals influence of DNA on metabolism
2025-10-03
A new study, published today in Nature Genetics, created the largest genetic map of human metabolism, revealing new insights on the role of metabolites in health and disease and creating a blueprint for further research.
Humans vary from person to person, and so does our metabolism. Yet, it is difficult to quantify precisely how much your genetic code contributes to this variability.
Using data from half a million individuals through the UK Biobank, the authors examined the consequences of variation in our genetic code on blood levels of 250 small molecules including lipid levels, which are important for a healthy heart, or amino acids. The study is the result of a collaborative ...
Researchers use ultrasound holograms to influence brain networks
2025-10-03
The first picture taken of a person nowadays is usually an ultrasound scan in the womb. But the technology is capable of much more than that. Physiotherapists have long used ultrasound to heat bodily tissues, and oncological surgeons use high-intensity ultrasound – and the heat it generates inside the body – to destroy tumours.
Over the last decade, scientists have also been researching how low-intensity ultrasound can be used to influence neural activity in the brain in a targeted manner. Initial clinical trials ...
Unique videos show how trawling restrictions brings back life to the sea
2025-10-03
Trawling restrictions not only benefits fish and shellfish; anemones and corals are also becoming more common, according to a new study from the University of Gothenburg. Twenty-six years of underwater videos from the depths of the Koster Sea also show long-term changes in the ecosystem as the water becomes warmer.
The marine wildlife in Kosterhavet National Park has changed rapidly in recent years. The introduction of trawling restrictions in the area for the national park during the last 25 years, brought about a change in the living conditions for the animals that live on the seabed.
“Animals ...